Michael Melnick

Dr. Melnick started his career in biotech as a Staff Scientist at New England Biolabs, then helped organize the spinoff company Cell Signaling Technology where he was VP of Business and Corporate Development. He has also worked in venture capital as a Venture Partner at CMEA Capital where he invested in life science, industrial biotech, and cleantech. He has a B.S. and M.S. in Biological Sciences from Stanford University, and a Ph.D. in Genetics from Harvard University.